Dr. Olson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 Civic Center Blvd
# Children
Philadelphia, PA 19104Phone+1 215-590-3535Fax+1 215-590-3992
Education & Training
- Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2008 - 2012
- Children's Hospital of PhiladelphiaResidency, Pediatrics, 2006 - 2008
- University of Virginia School of MedicineClass of 2006
Certifications & Licensure
- DE State Medical License Current
- PA State Medical License 2006 - 2024
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Fludarabine Based RIC for Bone Marrow Failure Syndromes Start of enrollment: 2015 Apr 01
- Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors Start of enrollment: 2019 Apr 03
Roles: Principal Investigator, Contact
- A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202) Start of enrollment: 2023 Jan 25
Roles: Contact
Publications & Presentations
PubMed
- 1 citationsSelf-organization of the hematopoietic vascular niche and emergent innate immunity on a chip.Andrei Georgescu, Joseph Hai Oved, Jonathan H Galarraga, Thomas Cantrell, Samira Mehta
Cell Stem Cell. 2024-12-05 - 1 citationsGenomic profiling of pediatric hematologic malignancies and diagnosis of cancer predisposition syndromes: tumoronlypaired tumor-normal sequencing.Haley Newman, Mary Egan Clark, Derek Wong, Jinhua Wu, Garrett M Brodeur
Haematologica. 2024-09-01 - Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia.Matthew P Connor, Neeharika Prathapa, Noelle V Frey, Saar I Gill, Elizabeth O Hexner
Haematologica. 2024-08-01
Journal Articles
- Germline Duplication of ATG2B and GSKIP Genes Is Not Required for the Familial Myeloid Malignancy Syndrome Associated with the Duplication of Chromosome 14q32David B Lieberman, Daria V Babushok, Timothy S Olson, Stella T Chou, Elizabeth O Hexner, Nature
Press Mentions
- Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone Marrow USA - English USA - Français USA - Nederlands Japan - Japanese Korea - 한국어 APAC - English USA - DeutschDecember 3rd, 2024
- Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone MarrowDecember 3rd, 2024
- Turn Bio Commences Bone Marrow Rejuvenation StudyDecember 3rd, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: